Events

Please join us for the 2023 Amsterdam Immunogenicity & Tolerance Seminar! The AIT2023 organizing committee is excited to share that the Seminar will take place on Friday, November 10th from 10:00AM – 6:00PM European Time, at the Hilton Apollolaan in Amsterdam.

The 15th annual 2023 Westin Immunogenicity Seminar will be taking place on Friday, September 29th.  The precise details, speakers and agenda will be announced soon- in the meantime, please Save the Date!

Updated: A big THANK YOU to everyone who joined us for our 25th Anniversary Party, held at our Providence, RI headquarters. We heard from good friends Vibha Jawa, Executive Director at Bristol Myers Squibb, and Seth Lederman, CEO of TONIX Pharmaceuticals, on the future of immunogenicity; new therapeutics, new vaccines, and new opportunities to improve human health. ...

Amsterdam Immunogenicity & Tolerance Seminar November 18, 2022 **Updated with Pictures and Recordings!****

We had a blast at AAPS PharmSci 360 in Boston! Thank you to everyone that attended our talks and poster sessions, and stopped by our booth or cocktail reception at Legal Seafoods! Pictures below!   Talks:  Anne De Groot, M.D., EpiVax, Inc. Deimmunization and Immune Tolerance Strategies for Protein Therapeutics: Extension of Principles to Novel Therapeutic Modalities Amy Rosenberg, M.D., ...

ISV 2022 Computational Vaccinology Pre-Conference Workshop September 17th, 2022 ***Updated with Pictures and Recordings!******

Westin Immunogenicity Seminar: September 9, 2022 **Updated with Pictures and Recordings!**

1st Annual Tregitope Summit - May 16, 2022 **Updated with Photos!**

The EpiVax team is excited to in-person at AAPS NBC 2022 in Anaheim, CA! Interested in connecting? Consider stopping by one of our presentations, or say hello to our team at Booth #301 in the exhibit hall! Additionally, you can request a meeting through the Connect360 portal. Our team would welcome the opportunity to hear about your ...

Gordon Research Conference on Biotherapeutics and Vaccines Development, March 2022

As a woman-led and women-owned company in biotech, EpiVax is a statistical outlier in the male dominated world of STEM. In an effort to address some of the gender disparities in our industry, Dr. Annie De Groot  and EpiVax’s Katie Porter launched the “Recipes for Success” podcast in 2021 to encourage discussion on this important topic, ...

Amsterdam Immunogenicity & Tolerance Seminar November 4-5, 2021 **Updated with Pictures and Recordings!**

From October 25th to the 28th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Scientific Director of Protein Therapeutics and Aimee Mattei, Immunoinformatics Program Manager, Peptide Therapeutics. Aimee and Brian will present the following posters! The posters will include a look at our What If Machine (WhIM),  ...

EpiVax had a large contingent at AAPS PharmSci360 in Philadelphia! Check out the EpiVax itinerary below! Always nice to connect with our partners, clients, and friends in Philly. Annie De Groot, MD Speaker Spotlight: Engineering Better Biologics: Does Nature Know Best? https://cdmcd.co/J6B7Lz Monday, October 18, 2021 3:30 PM – 4:30 PM ET Amy Rosenberg, MD Preparing for Success: Risk Assessment and ...

EpiVax participated in the  2021 International Society for Vaccines (ISV) Annual Virtual Congress September 13-15, 2021. The 2021 Congress was a busy one, it’s been a difficult but innovative period for the vaccine development community. Multiple EpiVax scientists presented throughout the three-day event, details below! EpiVax Director of Vaccine Research, Dr. Lenny Moise,  co-chaired the Plenary Session 2 ...

AAPS NBC Tech Challenge Talk: Engineering Better Biologics: Does Nature Know Best?

Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is free for AAPS members. This work builds off Aimee’s AAPS PharmSci360 poster session on in silico approaches for handling ...

FDA Webinar: Epitope Selection for Cancer Vaccines

FDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling

Antibody Industrial Symposium (AIS) 2020 Virtual

EpiVax is proud to have three of our Director and Senior level scientists representing our work at the 2020 AAPS PharmSci 360 Meetings. There are several opportunities to catch up with them over the next two weeks including the following rapid fire talks: Brian Roberts, PhD Rapid Fire: https://www.eventscribe.com/2020/PharmSci360/index.asp?presTarget=1414336 What Contributes to Immunogenicity? The API, Formulation, or the Impurities? Wednesday, ...

We are excited to share that our very own Annie De Groot was selected as a recipient of this year’s AAPS Global Health Award! View Annie’s acceptance speech here! The American Association of Pharmaceutical Scientists(AAPS) nominates one member annually for the Global Health Award, which recognizes AAPS members for their impact on their communities, both in the ...

PANDA: Immunogenicity of Peptide Drugs Webinar with Live Q&A

TIDES: Oligonucleotide and Peptide Therapeutics Virtual

Thank you for your continued interest in the status of our EpiVax’s EPV-CoV-19 Vaccine Program. This event has passed! But do not fear, there is a recording of the session available for access. Kindly fill out the information form linked below and an email containing the recording will be forwarded to you within 24 hours of ...

With the 2020 TIDES USA Virtual conference right around the corner, we at EpiVax are proud to sponsor this event, as we have year after year. Our CEO and leader in #FearlessScience Dr. Anne De Groot will be presenting a talk on a generic case study New Dogs/Old Tricks: Methods for Assessing the Immunogenicity of Peptide ...

Webinar: Tregitopes are Everywhere - Even in SARS-CoV-2 (COVID-19)

Webinar: Immune Engineering Human B cell-Derived Antibodies for Emerging Infectious Diseases

Webinar: Science in the Time of COVID-19

Working from work, working from home, working towards a vaccine for COVID-19

BIO EUROPE March 23-25, 2020

The 2020 meeting for the National Foundation for Infectious Diseases is taking place at the The Omni Shoreham Hotel in Washington DC, from March 23-25. During the meeting, EpiVax will be represented by Dr. Lenny Moise, director of Vaccines, Dr. Lauren Meyers, of the vaccine team, and Drasti Kanakia from the EpiVax lab team. Lauren will be ...

Dr. Brian Roberts, the Associate Scientific Director of Protein therapeutics at EpiVax will be heading to Kyoto, Japan for the 2020 AsiaTides meeting.  While there, he will be hosting: An Overview of Peptides and Immunogenicity workshop on day 1, February 24 at 12:00PM during the Current Topics in Peptide Discovery and Development: A Focus on ...

Dr. Anne De Groot will be going to Lisbon, Portugal to attend the European Immunogenicity Platform Symposium from 17-19th Feb.  While there, she will be giving a talk on EpiVax’s immunoinformatics platform on Day 2, 18Feb at 2:30PM.  The talk will focus on “The Two-Faced T cell Epitope and Janus Matrix; Relevance to Biologics and ...

Antigen-Specific Immune Tolerance Drug Development Meeting - February 25-27, 2020

Dr. Anne De Groot will be in Ventura Beach, CA for the Gordon Research Center: Advancing Peptides as Tools, Materials and Therapeutics Conference.  While there, Annie will be giving a talk on “Immunogenicity of Peptide Drugs and Their Impurities: Taspoglutide Case Study” during the Peptide Pathologes and Vaccines session on Thursday 13Jan at 7:30 PM. If you will ...

Katie Porter and Sarah Moniz from the Business Development team will be the the Keystone Symposia – Antibodies as Drugs in Santa Fe, New Mexico from February 2-6, 2020. While there, they will be at Poster Session 2 on February 4 with a poster showing the power of EpiVax’s immunogenicity prediction tools with clinical data validation.  ...

EpiVax’s Lauren Meyers will be at the ASM Biothreats in Arlington, VA on January 28-30, 2020. While there, Lauren will be presenting during the Ignite Session on Wednesday Jan 29 from 3:00 – 4:00PM.  There she will be presenting EpiVax’s collaborative work: Modulation of Regulatory Immune Responses by Human-Like T Cell Epitopes: Implications for Burkholderia Pseudomallei ...

On Thursday 16 and Friday 17 January 2020, Dr. Annie De Groot will be in attendance of the Vaccinology Club of the French Society for Immunology at the Institut Pasteur in Lille, France. There she will be speaking in Session 1 on Thursday 16 January at 10:15AM on Better Epitope Discovery, Precision Immune Engineering and Accelerated ...

The annual World Vaccine and Immunotherapy Congress west coast meetings will be held on December 2-5, 2019 at the San Francisco Airport Marriott Waterfront Hotel Dr. Lenny Moise, the Director of Vaccine Research at EpiVax will be in attendance.  His talk: “Engineering vaccine antigens to recruit CD4 T cell memory for enhanced antibody responses” will be will ...

From September 23rd to the 26th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Associate Scientific Director of Protein Therapeutics.  Dr. Roberts will present two posters on Tuesday September 24th, from 3:30PM – 5:30PM local time.  The posters will include a look at our What If Machine ...

Were you unable to meet the EpiVax team at our last event? No worries! Below is a list of where we will present throughout the year: January 23: Babraham Immunogenicity Seminar (Cambridge, United Kingdom) Hosted by: IONTAS and EpiVax, Inc. Title: Evolution of In Silico Tools for Predicting and In Vitro Assays for Validating T-Cell Response VIEW SLIDE DECK ...

Antibody Engineering & Therapeutics Monday, December 9th – Friday, December 13th Marriott Marquis San Diego, California Meet Sarah Moniz, Business Development Associate, at the largest antibody technology meeting, hosted by the Antibody Society, from December 9 to 12 at the Marriott Marquis in San Diego. Learn about EpiVax’s High Throughput Antibody Immunogenicity Prediction tool and report. ABOUT THIS CONFERENCE: Fast-track your ...

11th Annual Protein & Antibody Engineering Summit (PEGS) Europe Monday, November 18th – Friday, November 22nd Lisbon Congress Center Lisbon, Portugal Our European Representative, Paul Von Hoegen, and Business Development Associate, Sarah Moniz, will be present at PEGS Europe. The summit will take place November 18 through November 22 in Lisbon, Portugal. Network with our team and learn about ...

2019 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Hosted by the Defense Threat Reduction Agency (DTRA) Monday, November 18th – Thursday, November 21st Duke Energy Convention Center Cincinnati, Ohio Join Dr. Lenny Moise (Scientific Director of Vaccine Research) as he attends this year’s Chemical and Biological Defense Science & Technology Conference. This event will take place from ...

Updated:  Thank you to those that joined us for the seminar!  It was a successful meeting with many wonderful talks.  Please find photos from the event here as well as slide decks from some of our speakers. Welcome to Immunogenicity and Tolerance; Anne De Groot Tregitopes improve murine asthma by promoting highly suppressive and anitgen-specific TRegs; Marieme ...

TIDES Europe: Oligonucleotide and Peptide Therapeutics Tuesday, November 12th – Friday, November 15th RAI Amsterdam Convention Centre Amsterdam, Netherlands Right before our annual Immunogenicity and Tolerance seminar in Amsterdam, you will find us partnering at Europe’s #1 forum for oligonucleotide and peptide leaders, TIDES. Come network with us and learn about our newest technology, PANDA (peptide abbreviated new drug ...

25th Annual International Partnering Conference BIO-Europe Monday, November 11th – Wednesday, November 13th Hamburg Messe East Entrance Hamburg, Germany Network with EpiVax’s Business Development Manager, Katie Porter, and European Representative, Paul Von Hoegen, at BIO-Europe this Fall. Learn about EpiVax’s proprietary immunogenicity assessment tools. INTERESTED IN FORMALLY MEETING? Schedule a one-to-one with us via partneringONE! ABOUT BIO-EUROPE: BIO-Europe is more than just a conference; ...

UPDATE:  Review Dr. Anne De Groots presentation here Therapeutic Peptides and Oligonucleotides: Regulations, Standards and Quality USP Workshop Monday, November 4th – Tuesday, November 5th The U.S. Pharmacopoeia (USP) Therapeutic Peptides and Oligonucleotides: Regulations, Standards and Quality workshop is a 2-day event taking place November 4-5 in Rockville, Maryland. EpiVax’s Dr. De Groot has been invited to speak on ...

AAPS 2019 PharmSci360 Sunday, November 3rd – Wednesday, November 6th Henry B. Gonzalez Convention Center San Antonio, Texas Join Dr. De Groot as she attends this year’s AAPS PharmSci360, November 3-6, at the Henry B. Gonzalez Convention Center in San Antonio, Texas. STAY TUNED FOR MORE DETAILS ABOUT HER PRESENTATION! ABOUT AAPS PharmSci360: This event combines all the energy of a large ...